Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
Author(s) -
Josep Lluís Carbonell Esteve,
Tomasi,
Acosta,
Pérez,
Carlos Sanchez
Publication year - 2013
Publication title -
international journal of women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 45
ISSN - 1179-1411
DOI - 10.2147/ijwh.s42770
Subject(s) - mifepristone , medicine , double blind , placebo , myoma , randomized controlled trial , hormone antagonist , gynecology , surgery , uterus , pregnancy , antagonist , alternative medicine , biology , receptor , genetics , pathology
To evaluate the efficacy, safety, and quality of life of 5 mg mifepristone per day compared with a placebo in treating uterine fibroids.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom